Personalizing surgical margins in retroperitoneal sarcomas

References

• Stiller CA, Trama A, Serraino D, et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 2013;49(3):684-95
   PubMed Web of Science ®Google Scholar
• Brunicardi FC, Andersen DK, Billiar TR, et al. Soft Tissue Sarcomas. In: Cormier JN, Gronchi A, Pollock RE, Editors Schwartz’s Principles of Surgery. Tenth Edition. New York: McGraw-Hill Education; 1465-2015
   Google Scholar
• Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. International Agency for Research on Cancer, Lyon. 2013
   Google Scholar
• ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25(Suppl 3):iii102-12
   PubMed Web of Science ®Google Scholar
• Miah AB, Hannay J, Benson C, et al. Optimal management of primary retroperitoneal sarcoma: an update. Expert Rev Anticancer Ther 2014;14(5):565-79
   PubMed Web of Science ®Google Scholar
• EORTC. A Phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with Retroperitoneal sarcomas (RPS) - STRASS
   Google Scholar
• Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. 1980. Clin Orthop Relat Res 2003;415:4-18
   Google Scholar
• Enneking WF, Spanier SS, Malawer MM. The effect of the Anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh. Cancer 1981;47(5):1005-22
   PubMed Web of Science ®Google Scholar
• Enneking WF, Maale GE. The effect of inadvertent tumor contamination of wounds during the surgical resection of musculoskeletal neoplasms. Cancer 1988;62(7):1251-6
   PubMedGoogle Scholar
• Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14(5):1679-89
   PubMed Web of Science ®Google Scholar
• Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 2003;97(10):2530-43
   PubMed Web of Science ®Google Scholar
• Trovik CS, Bauer HC, Alvegard TA, et al. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000;36(6):710-16
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Leung DH, Allen P, et al. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol 2002;20(21):4344-52
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Leung DH, Hoos A, et al. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 2002;235(3):424-34
   PubMed Web of Science ®Google Scholar
• Gronchi A, Casali PG, Mariani L, et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol 2005;23(1):96-104
   PubMed Web of Science ®Google Scholar
• Stoeckle E, Gardet H, Coindre JM, et al. Prospective evaluation of quality of surgery in soft tissue sarcoma. Eur J Surg Oncol 2006;32(10):1242-8
   PubMed Web of Science ®Google Scholar
• Gronchi A, Lo Vullo S, Colombo C, et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg 2010;251(3):506-11
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196(3):305-15
   PubMed Web of Science ®Google Scholar
• Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14(3):859-68
   PubMed Web of Science ®Google Scholar
• Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16(1):197-203
   PubMed Web of Science ®Google Scholar
• Koea JB, Leung D, Lewis JJ, Brennan MF. Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity? Ann Surg Oncol 2003;10(4):432-40
   PubMed Web of Science ®Google Scholar
• Kawaguchi N, Matumoto S, Manabe J. New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol 1995;121(9-10):555-63
   PubMed Web of Science ®Google Scholar
• Kawaguchi N, Ahmed AR, Matsumoto S, et al. The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 2004(419):165-72
   PubMed Web of Science ®Google Scholar
• Gerrand CH, Wunder JS, Kandel RA, et al. Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br 2001;83(8):1149-55
   PubMedGoogle Scholar
• O’Donnell PW, Griffin AM, Eward WC, et al. The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer 2014;120(18):2866-75
   PubMedGoogle Scholar
• Tirkes T, Sandrasegaran K, Patel AA, et al. Peritoneal and retroperitoneal anatomy and its relevance for cross-sectional imaging. Radiographics 2012;32(2):437-51
   PubMed Web of Science ®Google Scholar
• Culligan K, Coffey JC, Kiran RP, et al. The mesocolon: a prospective observational study. Colorectal Dis 2012;14(4):421-8; discussion 428-30
   PubMed Web of Science ®Google Scholar
• Bonvalot S, Raut CP, Pollock RE, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol 2012;19(9):2981-91
   PubMed Web of Science ®Google Scholar
• Anaya DA, Lahat G, Liu J, et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg 2009;249(1):137-42
   PubMedGoogle Scholar
• Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228(3):355-65
   PubMed Web of Science ®Google Scholar
• Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001;92(2):359-68
   PubMedGoogle Scholar
• van Dalen T, Plooij JM, van Coevorden F, et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol 2007;33(2):234-8
   PubMedGoogle Scholar
• Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 2009;27(1):24-30
   PubMed Web of Science ®Google Scholar
• Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009;27(1):31-7
   PubMed Web of Science ®Google Scholar
• Toulmonde M, Bonvalot S, Meeus P, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol 2014;25(3):735-42
   PubMed Web of Science ®Google Scholar
• Gronchi A, Miceli R, Allard MA, et al. Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma: histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection. Ann Surg Oncol 2014. [Epub ahead of print]
   Google Scholar
• Strauss DC, Hayes AJ, Thway K, et al. Surgical management of primary retroperitoneal sarcoma. Br J Surg 2010;97(5):698-706
   PubMedGoogle Scholar
• Bremjit PJ, Jones RL, Chai X, et al. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma. Ann Surg Oncol 2014;21(7):2150-8
   PubMedGoogle Scholar
• Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol 2013;31(13):1649-55
   PubMed Web of Science ®Google Scholar
• Anaya DA, Lev DC, Pollock RE. The role of surgical margin status in retroperitoneal sarcoma. J Surg Oncol 2008;98(8):607-10
   PubMedGoogle Scholar
• Keung EZ, Hornick JL, Bertagnolli MM, et al. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg 2014;218(2):206-17
   PubMedGoogle Scholar
• van Dalen T, Hennipman A, Van Coevorden F, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol 2004;11(5):483-90
   PubMed Web of Science ®Google Scholar
• Gutierrez JC, Perez EA, Moffat FL, et al. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg 2007;245(6):952-8
   PubMed Web of Science ®Google Scholar
• Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: a Consensus Approach From the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2015;22(1):256-63
   PubMedGoogle Scholar
• von Mehren M, Randall RL, Benjamin RS, et al. Soft tissue sarcoma, version 2.2014. J Natl Compr Canc Netw 2014;12(4):473-83
   PubMed Web of Science ®Google Scholar
• Nathan H, Raut CP, Thornton K, et al. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg 2009;250(6):970-6
   PubMed Web of Science ®Google Scholar
• Ardoino I, Miceli R, Berselli M, et al. Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma. Cancer 2010;116(10):2429-36
   PubMed Web of Science ®Google Scholar
• Anaya DA, Lahat G, Wang X, et al. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol 2010;21(2):397-402
   PubMed Web of Science ®Google Scholar
• Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg 1991;214(1):2-10
   PubMed Web of Science ®Google Scholar
• Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg 2004;239(2):244-50
   PubMed Web of Science ®Google Scholar
• Karakousis CP, Kontzoglou K, Driscoll DL. Resectability of retroperitoneal sarcomas: a matter of surgical technique? Eur J Surg Oncol 1995;21(6):617-22
   PubMedGoogle Scholar
• Strauss DC. Patterns of recurrence in retroperitoneal liposarcomas: reflecting surgical approach or tumor biology? Ann Surg Oncol 2014;21(7):2113-16
   PubMedGoogle Scholar
• Mussi C, Colombo P, Bertuzzi A, et al. Retroperitoneal sarcoma: is it time to change the surgical policy? Ann Surg Oncol 2011;18(8):2136-42
   PubMedGoogle Scholar
• Tsivian A, Lev-Chelouche D, Shtabsky A, et al. Aggressive resection of retroperitoneal sarcoma is superior to simple excision: an animal study using a novel model for retroperitoneal sarcoma. J Surg Oncol 2002;81(3):144-7
   PubMedGoogle Scholar
• Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol 2012;23(4):1067-73
   PubMed Web of Science ®Google Scholar
• Pisters PW. Resection of some – but not all – clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol 2009;27(1):6-8
   PubMedGoogle Scholar
• Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol 2010;17(6):1507-14
   PubMedGoogle Scholar
• Tseng WH, Martinez SR, Tamurian RM, et al. Contiguous organ resection is safe in patients with retroperitoneal sarcoma: an ACS-NSQIP analysis. J Surg Oncol 2011;103(5):390-4
   PubMedGoogle Scholar
• Lahat G, Anaya DA, Wang X, et al. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Oncol 2008;15(6):1585-93
   PubMedGoogle Scholar
• Russo P, Kim Y, Ravindran S, et al. Nephrectomy during operative management of retroperitoneal sarcoma. Ann Surg Oncol 1997;4(5):421-4
   PubMedGoogle Scholar
• Anaya DA, Lahat G, Wang X, et al. Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. Ann Surg Oncol 2009;16(3):667-75
   PubMedGoogle Scholar
• Brown RE, St Hill CR, Greene QJ, et al. Impact of histology on survival in retroperitoneal sarcomas. Am J Surg 2011;202(6):748-52; discussion 752-3
   PubMedGoogle Scholar
• Lehnert T, Cardona S, Hinz U, et al. Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival. Eur J Surg Oncol 2009;35(9):986-93
   PubMedGoogle Scholar
• Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 2006;244(3):381-91
   PubMed Web of Science ®Google Scholar
• Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003;238(3):358-70; discussion 370-1
   PubMed Web of Science ®Google Scholar
• Tseng WW, Madewell JE, Wei W, et al. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol 2014;21(7):2136-43
   PubMedGoogle Scholar
• Gronchi A. Extended surgery for retroperitoneal sarcoma: the key to maximizing the potential for cure and survival. Oncology (Williston Park) 2013;27(7):640, 642
   Google Scholar
• Pollock RE. Extended surgery for retroperitoneal sarcoma: too much surgery for some and not enough for others? Oncology (Williston Park) 2013;27(7):641-2
   PubMedGoogle Scholar
• Gronchi A, Pollock RE. Quality of local treatment or biology of the tumor: which are the trump cards for loco-regional control of retroperitoneal sarcoma? Ann Surg Oncol 2013;20(7):2111-13
   PubMedGoogle Scholar
• Mussi C, Collini P, Miceli R, et al. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer 2008;113(7):1657-65
   PubMedGoogle Scholar
• Neuhaus SJ, Barry P, Clark MA, et al. Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg 2005;92(2):246-52
   PubMedGoogle Scholar
• Radaelli S, Stacchiotti S, Casali PG, Gronchi A. Emerging therapies for adult soft tissue sarcoma. Expert Rev Anticancer Ther 2014;14(6):689-704
   PubMed Web of Science ®Google Scholar
• Dickson MA, Tap WD, Keohan ML, et al. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. J Clin Oncol 2013;31(16):2024-8
   PubMed Web of Science ®Google Scholar
• Ray-Coquard I, Blay JY, Italiano A, et al. Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. Lancet Oncol 2012;13(11):1133-40
   PubMed Web of Science ®Google Scholar
• Gronchi A, Collini P, Miceli R, et al. Myogenic Differentiation and Histologic Grading Are Major Prognostic Determinants in Retroperitoneal Liposarcoma. Am J Surg Pathol 2015;39(3):383-93
   PubMed Web of Science ®Google Scholar
• Ghadimi MP, Al-Zaid T, Madewell J, et al. Diagnosis, management, and outcome of patients with dedifferentiated liposarcoma systemic metastasis. Ann Surg Oncol 2011;18(13):3762-70
   PubMed Web of Science ®Google Scholar
• Gyorki DE, Brennan MF. Management of recurrent retroperitoneal sarcoma. J Surg Oncol 2014;109(1):53-9
   PubMedGoogle Scholar
• Park JO, Qin LX, Prete FP, et al. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule. Ann Surg 2009;250(6):977-82
   PubMed Web of Science ®Google Scholar
• de Vreeze RS, de Jong D, Tielen IH, et al. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis. Mod Pathol 2009;22(2):223-31
   PubMedGoogle Scholar
• Pitson G, Robinson P, Wilke D, et al. Radiation response: an additional unique signature of myxoid liposarcoma. Int J Radiat Oncol Biol Phys 2004;60(2):522-6
   PubMed Web of Science ®Google Scholar
• Jones RL, Fisher C, Al-Muderis O, Judson IR. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer 2005;41(18):2853-60
   PubMed Web of Science ®Google Scholar
• Fiore M, Grosso F, Lo Vullo S, et al. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution. Cancer 2007;109(12):2522-31
   PubMed Web of Science ®Google Scholar
• Mingoli A, Cavallaro A, Sapienza P, et al. International registry of inferior vena cava leiomyosarcoma: analysis of a world series on 218 patients. Anticancer Res 1996;16(5B):3201-5
   Google Scholar
• Fiore M, Colombo C, Locati P, et al. Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava. Ann Surg Oncol 2012;19(2):511-18
   PubMedGoogle Scholar
• Cranshaw IM, Gikas PD, Fisher C, et al. Clinical outcomes of extra-thoracic solitary fibrous tumours. Eur J Surg Oncol 2009;35(9):994-8
   PubMed Web of Science ®Google Scholar
• Gold JS, Antonescu CR, Hajdu C, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer 2002;94(4):1057-68
   PubMed Web of Science ®Google Scholar
• Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. Extrapleural solitary fibrous tumour. In: Fletcher CDM, Bridge JA, Lee J, Editors), WHO Classification of Tumours of Soft Tissue and Bone. Lyon International Agency for Research on Cancer, 2013;80.
   Google Scholar